Logotipo do repositório
 

Publicação:
The presence of ASXL1 mutations as well as a total number of myeloid driver mutations higher than two is strongly associated with the diagnosis of primary myelofibrosis as opposed to essential thrombocythemia

Página do item simplificado
dc.contributor.authorCampregher, Paulo Vidal
dc.contributor.authorHelman, Ricardo
dc.contributor.authorPereira, Welbert Oliveira
dc.contributor.authorPuga, Renato D.
dc.contributor.authorLisboa, Bianca
dc.contributor.authorAscendino, Evelyn Helena
dc.contributor.authorMiyagi, Mariana
dc.contributor.authorYoshida, Sandra Nakashima
dc.contributor.authorBello, Isabel C.
dc.contributor.authorDiniz, Michelli Silva
dc.contributor.authorPerini, Guilherme Fleury
dc.contributor.authorDatoguia, Tarcila S.
dc.contributor.authorVelloso, Elvira
dc.contributor.authorGuerra, Joao Carlos
dc.contributor.authorSilveira, Paulo A. A.
dc.contributor.authorBacal, Nydia
dc.contributor.authorPetroni, Roberta Cardoso
dc.contributor.authorMusacchio, Juliane
dc.contributor.authorSantucci, Rodrigo
dc.contributor.authorSchriefer, Ana Fernandes
dc.contributor.authorSalvino, Marco A.
dc.contributor.authorSoares, Rodolfo
dc.contributor.authorTiburcio, Manuela Pinto
dc.contributor.authorPerobelli, Leila Martins
dc.contributor.authorSouto, Eizabeth Xisto
dc.contributor.authorCordeiro De Farias, Danielle Leao
dc.contributor.authorHigashi, Marcia
dc.contributor.authorFadel, Adriana Valente [UNESP]
dc.contributor.authorKassab, Carolina
dc.contributor.authorPadua, Leandro
dc.contributor.authorBollman, Patricia W.
dc.contributor.authorPasqualin, Denise da Cunha
dc.contributor.authorBezerra, Alanna Mara P. S.
dc.contributor.authorLima, Marinus de Moraes
dc.contributor.authorCosta, Erika M. M.
dc.contributor.authorMattos, Vinicius R. P.
dc.contributor.authorCosta, Fernando Ferreira
dc.contributor.authorHamerschlak, Nelson
dc.contributor.authorDe Souza Santos, Fabio Pires
dc.contributor.institutionHosp Israelita Albert Einstein
dc.contributor.institutionUniversidade Estadual de Campinas (UNICAMP)
dc.contributor.institutionClin Oncol Integrada
dc.contributor.institutionCoi Clin Oncol Int
dc.contributor.institutionHEMOMED
dc.contributor.institutionUniversidade Federal da Bahia (UFBA)
dc.contributor.institutionUniv Fed Rio Grande do Norte
dc.contributor.institutionHosp Brigadeiro
dc.contributor.institutionHosp Clin Univ Fed Goias
dc.contributor.institutionFundacao Hosp Amaral Carvalho
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionCtr Hematol Sao Paulo
dc.contributor.institutionHosp Leforte
dc.contributor.institutionHosp Mario Covas
dc.contributor.institutionIsraelita Albert Einstein Hosp
dc.date.accessioned2015-11-03T18:24:38Z
dc.date.available2015-11-03T18:24:38Z
dc.date.issued2014-12-06
dc.description.affiliationHosp Israelita Albert Einstein, Sao Paulo, Brazil
dc.description.affiliationUniv Estadual Campinas, Campinas, SP, Brazil
dc.description.affiliationClin Oncol Integrada, Rio De Janeiro, Brazil
dc.description.affiliationCoi Clin Oncol Int, Rio De Janeiro, Brazil
dc.description.affiliationHEMOMED, Sao Paulo, Brazil
dc.description.affiliationUniv Fed Bahia, Salvador, BA, Brazil
dc.description.affiliationUniv Fed Rio Grande do Norte, Nucleo Hematol Hemoterapia, BR-59072970 Natal, RN, Brazil
dc.description.affiliationUniv Fed Rio Grande do Norte, BR-59072970 Natal, RN, Brazil
dc.description.affiliationHosp Brigadeiro, Sao Paulo, Brazil
dc.description.affiliationHosp Clin Univ Fed Goias, Goiania, Go, Brazil
dc.description.affiliationFundacao Hosp Amaral Carvalho, Jau, Brazil
dc.description.affiliationUNESP, Botucatu, SP, Brazil
dc.description.affiliationCtr Hematol Sao Paulo, Sao Paulo, Brazil
dc.description.affiliationHosp Leforte, Sao Paulo, Brazil
dc.description.affiliationHosp Mario Covas, Santo Andre, Brazil
dc.description.affiliationIsraelita Albert Einstein Hosp, Sao Paulo, Brazil
dc.description.affiliationUniv Campinas UNICAMP, Inst Nacl Ciencia &Tecnol Sangue, Campinas, SP, Brazil
dc.description.affiliationUnespUNESP, Botucatu, SP, Brazil
dc.format.extent1-4
dc.identifierhttp://www.bloodjournal.org/content/124/21/4595
dc.identifier.citationBlood. Washington: Amer Soc Hematology, v. 124, n. 21, p. 1-4, 2014.
dc.identifier.issn0006-4971
dc.identifier.urihttp://hdl.handle.net/11449/130341
dc.identifier.wosWOS:000349242703166
dc.language.isoeng
dc.publisherAmer Soc Hematology
dc.relation.ispartofBlood
dc.relation.ispartofjcr15.132
dc.relation.ispartofsjr6,434
dc.rights.accessRightsAcesso aberto
dc.sourceWeb of Science
dc.titleThe presence of ASXL1 mutations as well as a total number of myeloid driver mutations higher than two is strongly associated with the diagnosis of primary myelofibrosis as opposed to essential thrombocythemiaen
dc.typeResumo
dcterms.rightsHolderAmer Soc Hematology
dspace.entity.typePublication
unesp.author.orcid0000-0002-5140-5310[38]
unesp.author.orcid0000-0002-9707-0579[13]
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Medicina, Botucatupt
unesp.departmentClínica Médica - FMBpt

Arquivos

Coleções

Botucatu - FMB - Faculdade de Medicina